Stockhead Presents: Vital Signs
oleh Stockhead
EZZ Life Science targets Global Wellness Growth
Tentang podcast ini
Stockhead's Health and Biotech reporter Nadine McGrath is joined by industry experts to discuss healthcare and biotechnology investments.
Hear insights from leaders, innovators, and investors who are shaping the future of healthcare.
Whether you're an investor looking for the next big opportunity, a professional in the field, or simply curious about the advancements transforming healthcare, Vital Signs provides valuable insights and fascinating information.
Hear about cutting-edge technologies, groundbreaking research, and the financial strategies driving success in the biotech world.
Subscribe now to be a part of the exciting landscape of health and biotech investment.
Episode
- EZZ Life Science targets Global Wellness Growth · 16 mntIn this episode, Nadine speaks to EZZ Life Science Chief Strategy Officer Glenn Cross. He discusses the company’s expanding health and wellness business across Australia and…
- Inside Prescient Therapeutics' fight against a rare blood cancer · 17 mntStockhead's Vital Signs sits down with Prescient Therapeutics (ASX:PTX) CEO James McDonnell to unpack PTX-100, a first-in-class cancer therapy targeting the RAS pathway…
- MASTRR study redefining regenerative healing - Aroa Biosurgery (ASX:ARX) · 24 mntIn today's episode, Nadine speaks to Dr. Adam Young of Aroa Biosurgery (ASX:ARX) Learn more about your ad choices. Visit megaphone.fm/adchoices
- Vital Signs Podcast: Health Food Symmetry · 12 mntIn today's episode, Nadine speaks to Gordon Edwards, CEO of Health Food Symmetry Learn more about your ad choices. Visit megaphone.fm/adchoices
- Redefining hearing health with personalised sound technology-Audeara (ASX:AUA) · 29 mntIn today's episode, Nadine speaks to Dr. James Fielding, CEO of Audeara (ASX:AUA) Learn more about your ad choices. Visit megaphone.fm/adchoices
- Prescient eyes FDA fast track for cancer drug treatment | Prescient Therapeutics (ASX:PTX) · 17 mntIn today's episode, Nadine speaks to James McDonnell, CEO of Prescient Therapeutics (ASX:PTX) Learn more about your ad choices. Visit megaphone.fm/adchoices
- Heartfelt & WiSE: EBR embarks on new growth chapter after US FDA approval · 19 mntIn today's episode, Nadine speaks to John McCutcheon President & CEO of EBR Systems (ASX:EBR) Learn more about your ad choices. Visit megaphone.fm/adchoices
- Breakthrough brain scanning technology overcoming diagnostic hurdles - Compumedics (ASX:CMP) · 15 mntIn today's episode, Nadine speaks to Gordon Haid, Global Neuro-Imaging Business Director of Compumedics (ASX:CMP) Learn more about your ad choices. Visit megaphone.fm/adchoices
- Clever Culture Systems' shift to big pharma clients is perfect prescription - Clever Culture Systems (ASX:CC5) · 19 mntIn today's episode, Nadine speaks to Brent Barnes, CEO and Managing Director of Clever Culture Systems (ASX:CC5) Learn more about your ad choices. Visit megaphone.fm/adchoices
- Pioneering Pathology's Digital Future - Optiscan (ASX:OIL) · 23 mntIn today's episode, Nadine speaks to Dr Camile Farah, CEO of Optiscan (ASX:OIL) Learn more about your ad choices. Visit megaphone.fm/adchoices
- "A global giant recognised our innovation" - Wellnex Life (ASX:WNX) · 16 mntIn today's episode, Nadine speaks to Zack Bozinovski, Executive Director of Wellnex Life (ASX:WNX). Learn more about your ad choices. Visit megaphone.fm/adchoices
- "Unlocking regenerative medicine for everybody" - Aroa Biosurgery (ASX:ARX) · 15 mntIn today's episode, Nadine speaks to Dr. Adam Young, Vice President of Medical Affairs at Aroa Biosurgery (ASX:ARX). Learn more about your ad choices. Visit megaphone.fm/adchoices
- "We want to become a dominant figure in wound care" - Aroa Biosurgery (ASX:ARX) | Vital Signs · 18 mntIn today's episode, Nadine speaks to James Agnew, CFO of Aroa Biosurgery (ASX:ARX) to discuss New Zealand's history of medical advancements and how Aroa is looking to become a…
- "Truly life-changing technology" - Optiscan (ASX:OIL) | Vital Signs · 26 mntIn today's episode, Nadine speaks to Dr Camile Farah, CEO of Optiscan (ASX:OIL) to discuss the fascinating history of the real time frozen section, breakthrough discoveries in…








